InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by MAIER PAUL V. Director active across 1 company, notably Ambrx Biopharma Inc.. Cumulatively, 1 reports have been published. Activity tracked since 7 June 2023. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration